SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy
PremiumPress ReleasesSciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy
4d ago
SciSparc Funds AutoMax, Secures Import Deal
Premium
Company Announcements
SciSparc Funds AutoMax, Secures Import Deal
9d ago
SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer
Premium
Press Releases
SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax’s Direct Import Agreement with Major Chinese Vehicle Manufacturer
9d ago
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
PremiumPress ReleasesSciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
14d ago
SciSparc and Clearmind Innovate in Mental Health Therapy
Premium
Company Announcements
SciSparc and Clearmind Innovate in Mental Health Therapy
22d ago
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination
Premium
Press Releases
SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination
22d ago
SciSparc Advances Tourette Syndrome Drug Trial
PremiumCompany AnnouncementsSciSparc Advances Tourette Syndrome Drug Trial
25d ago
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome
Premium
Press Releases
SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome
28d ago
SciSparc submits IND application to FDA for SCI-110 Phase IIb trial
Premium
The Fly
SciSparc submits IND application to FDA for SCI-110 Phase IIb trial
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100